Metabolic-Dysfunction-Associated Steatotic Liver Disease at the Forefront: Confronting Nutritional Obstacles in Advanced Chronic Liver Disease and Portal Hypertension
A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Clinical Nutrition".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 56
Special Issue Editors
2. Metabolic Liver Disease Research Program, I. Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany
Interests: liver diseases; non-alcoholic fatty liver disease; NASH; portal hypertension; liver fibrosis; hepatocellular carcinoma; liver cirrhosis; spleen stiffness; sarcopenia; nutrition in liver disease; insulin resistance
Interests: nutrition in liver diseases; cirrhosis; sarcopenic obesity; hepatocellular carcinoma; portal hypertension; metabolic dysfunction–associated steatotic liver disease; non-invasive tests; liver stiffness; spleen stiffness; varices
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the realm of clinical nutrition for patients with advanced chronic liver disease, it is imperative to adopt an individualized and meticulous approach, as recommended by prominent guidelines, such as EASL, ESPEN, and AGA. Beyond focusing solely on etiological therapy, thorough nutritional evaluation and management are crucial components, especially in the context of portal hypertension and its associated complications, such as end-stage liver disease, infectious ailments, sarcopenia, and encephalopathy. Notably, in obese individuals with advanced liver disease, conditions including metabolic-dysfunction-associated steatotic liver disease (MASLD) often lead to the development of sarcopenia and malnutrition, creating a scenario known as “sarcopenic obesity“. This condition not only leads to deterioration in the prognosis of liver cirrhosis by escalating patients’ susceptibility to infections but also diminishes overall survival rates. Additionally, the presence of obesity and malnutrition in cirrhotic patients impairs the technical feasibility of orthotopic liver transplantation.
Expanding upon the outlined topics, the following critical areas warrant in-depth exploration:
- Commercial Diets, Meal Replacements, Vegan Diet, and New Intermittent-Fasting Diets: Applicability and Evidence in Patients with Chronic Liver Disease: The utilization of commercial diets, meal replacements, and emerging intermittent-fasting regimens as potential interventions for managing chronic liver diseases. Submissions exploring the scientific basis and clinical applications of these dietary approaches in the context of advanced chronic liver disease are encouraged.
- Assessment of Sarcopenia and Sarcopenic Obesity in Patients with ACLD: Comprehensive assessment strategies, including imaging modalities, biochemical markers, and physical performance tests, for identifying sarcopenia and sarcopenic obesity in patients afflicted with advanced chronic liver disease. Original research contributions, epidemiological studies, and systematic reviews shedding light on the diagnostic criteria and evaluation methods for these conditions are welcome.
- Association Between Diet and Natural History of ACLD, with regard to Infections and Liver Decompensation: Research investigating the intricate relationship between dietary interventions and the natural disease progression of advanced chronic liver disease, particularly focusing on the impacts on infections and liver decompensation. Original contributions, epidemiological studies, and narrative and systematic reviews, as well as meta-analyses elucidating the association between dietary patterns and the clinical outcomes of patients with ACLD, are encouraged.
Dr. Angelo Armandi
Dr. Federico Ravaioli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcopenic obesity
- portal hypertension
- cirrhosis
- MASLD
- MASH
- NAFLD
- NASH
- MAFLD
- advanced chronic liver disease
- nutritional supplementation
- diet
- sport
- hepatic decompensation
- hepatocellular carcinoma
